Cargando…
Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds
Despite advances in characterizing genetic influences on addiction liability and treatment response, clinical applications of these efforts have been slow to evolve. Although challenges to clinical translation remain, stakeholders already face decisions about evidentiary thresholds for the uptake of...
Autor principal: | Hendershot, Christian S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165632/ https://www.ncbi.nlm.nih.gov/pubmed/25217046 http://dx.doi.org/10.1186/1940-0640-9-20 |
Ejemplares similares
-
Towards the clinical implementation of pharmacogenetics in bipolar disorder
por: Salloum, Naji C, et al.
Publicado: (2014) -
The utility of pharmacogenetic testing to support the treatment of bipolar disorder
por: Ielmini, Marta, et al.
Publicado: (2018) -
S222. CLINICAL UTILITY OF PHARMACOGENETIC TESTING IN SCHIZOPHRENIA TREATMENT
por: Mueller, Daniel, et al.
Publicado: (2018) -
Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders
por: Blasco-Fontecilla, Hilario
Publicado: (2018) -
Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022)